{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:36Z","timestamp":1790643996752,"version":"4.1.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Autoimmune diseases recognize a multifactorial pathogenesis, although the exact mechanism responsible for their onset remains to be fully elucidated. Over the past few years, the role of natural killer (NK) cells in shaping immune responses has been highlighted even though their involvement is profoundly linked to the subpopulation involved and to the site where such interaction takes place. The aberrant number and functionality of NK cells have been reported in several different autoimmune disorders. In the present review, we report the most recent findings regarding the involvement of NK cells in both systemic and organ-specific autoimmune diseases, including type 1 diabetes (T1D), primary biliary cholangitis (PBC), systemic sclerosis, systemic lupus erythematosus (SLE), primary Sj\u00f6gren syndrome, rheumatoid arthritis, and multiple sclerosis. In T1D, innate inflammation induces NK cell activation, disrupting the Treg function. In addition, certain genetic variants identified as risk factors for T1D influenced the activation of NK cells promoting their cytotoxic activity. The role of NK cells has also been demonstrated in the pathogenesis of PBC mediating direct or indirect biliary epithelial cell destruction. NK cell frequency and number were enhanced in both the peripheral blood and the liver of patients and associated with increased NK cell cytotoxic activity and perforin expression levels. NK cells were also involved in the perpetuation of disease through autoreactive CD4 T cell activation in the presence of antigen-presenting cells. In systemic sclerosis (SSc), in addition to phenotypic abnormalities, patients presented a reduction in CD56\n                    <jats:sup>hi<\/jats:sup>\n                    NK-cells. Moreover, NK cells presented a deficient killing activity. The influence of the activating and inhibitory killer cell immunoglobulin-like receptors (KIRs) has been investigated in SSc and SLE susceptibility. Furthermore, autoantibodies to KIRs have been identified in different systemic autoimmune conditions. Because of its role in modulating the immune-mediated pathology, NK subpopulation could represent a potential marker for disease activity and target for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.616853","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T19:30:33Z","timestamp":1613849433000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?"],"prefix":"10.3389","volume":"12","author":[{"given":"Elena","family":"Gianchecchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico V.","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fierabracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK cells in autoimmune diseases: linking innate and adaptive immune responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/eji.1830050209","article-title":"Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. characteristics of the killer cell","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fimmu.2014.00105","article-title":"TLR\/NCR\/KIR: which one to use and when?","volume":"5","author":"Sivori","year":"2014","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.12330","article-title":"Selection, tuning, and adaptation in mouse NK cell education","volume":"267","author":"Kadri","year":"2015","journal-title":"Immunol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity."},{"key":"B9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/cyto.a.24001","article-title":"Comprehensive phenotyping of human PB NK cells by flow cytometry","volume":"97","author":"Del Zotto","year":"2020","journal-title":"Cytometry A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00439-015-1579-9","article-title":"KIR and HLA under pressure: evidences of coevolution across worldwide populations","volume":"134","author":"Augusto","year":"2015","journal-title":"Hum Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.12688\/f1000research.6754.1","article-title":"Cytotoxic granule secretion by lymphocytes and its link to immune homeostasis","volume":"4","author":"de Saint Basile","year":"2015","journal-title":"F1000Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/ar1034","article-title":"Natural killer cells and autoimmunity","volume":"6","author":"French","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"B14","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.4049\/jimmunol.0903354","article-title":"The interactions of multiple cytokines control NK cell maturation","volume":"185","author":"Brady","year":"2010","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3389\/fimmu.2013.00450","article-title":"Regulation of mouse NK cell development and function by cytokines","volume":"4","author":"Mar\u00e7ais","year":"2013","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.smim.2014.02.008","article-title":"Human natural killer cell development in secondary lymphoid tissues","volume":"26","author":"Freud","year":"2014","journal-title":"Semin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000382019","article-title":"Human cytokine-induced memory-like natural killer cells","volume":"7","author":"Berrien-Elliott","year":"2015","journal-title":"J Innate Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10&lt;3121::AID-IMMU3121&gt;3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4049\/jimmunol.1500591","article-title":"CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2105-7-325","article-title":"The autoimmune disease database: a dynamically compiled literature-derived database","volume":"7","author":"Karopka","year":"2006","journal-title":"BMC Bioinformatics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nri2787","article-title":"Immune cell crosstalk in type 1 diabetes","volume":"10","author":"Lehuen","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1172\/JCI112390","article-title":"Spontaneous diabetes mellitus in the Bio-Breeding\/Worcester rat. evidence in vitro for natural killer cell lysis of islet cells","volume":"77","author":"MacKay","year":"1986","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1096\/fba.2019-00031","article-title":"Kinetics of immune cell responses in the multiple low-dose streptozotocin mouse model of type 1 diabetes","volume":"1","author":"Luo","year":"2019","journal-title":"FASEB Bioadv."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.2337\/db19-0287","article-title":"Early detection of peripheral blood cell signature in children developing \u03b2-Cell autoimmunity at a young age","volume":"68","author":"Kallionp\u00e4\u00e4","year":"2019","journal-title":"Diabetes."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3389\/fimmu.2019.02547","article-title":"Phenotypic analysis of human lymph nodes in subjects with new-onset type 1 diabetes and healthy individuals by flow cytometry","volume":"10","author":"Yang","year":"2019","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"102417","DOI":"10.1016\/j.jaut.2020.102417","article-title":"Innate inflammation drives NK cell activation to impair Treg activity","volume":"108","author":"Dean","year":"2020","journal-title":"J Autoimmun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ijms19030794","article-title":"Type 1 diabetes and its multi-factorial pathogenesis: the putative role of NK cells","volume":"19","author":"Marca","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.13332","article-title":"A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients","volume":"198","author":"Oras","year":"2019","journal-title":"Clin Exp Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3389\/fimmu.2019.00982","article-title":"Mass cytometry identifies distinct subsets of regulatory T cells and natural killer cells associated with high risk for Type 1 diabetes","volume":"10","author":"Barcenilla","year":"2019","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2020.00288","article-title":"Mass cytometry studies of patients with autoimmune endocrine diseases reveal distinct disease-specific alterations in immune cell subsets","volume":"11","author":"Magnusson","year":"2020","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu Rev Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bpg.2018.05.013","article-title":"PBC and related extrahepatic diseases","author":"Floreani","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis","volume":"133","author":"Ma","year":"2019","journal-title":"Clin Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaut.2006.04.001","article-title":"Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis","volume":"26","author":"Chuang","year":"2006","journal-title":"J Autoimmun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/hep.24275","article-title":"Natural killer cells take two tolls to destruct bile ducts","volume":"53","author":"Gao","year":"2011","journal-title":"Hepatology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2019.05.023","article-title":"Interferon-\u03b3-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"71","author":"Ravichandran","year":"2019","journal-title":"J Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive activation of natural killer cells in primary biliary cholangitis","volume":"10","author":"Hydes","year":"2019","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0168-8278(20)30917-X","article-title":"Integrated GWAS and mRNA microarray analysis identified IFNG and CD40L as the central upstream regulators in primary biliary cholangitis","volume":"4","author":"Ueno","year":"2020","journal-title":"Hepatol Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Relat Disorders."},{"key":"B48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/ard.52.4.272","article-title":"Early phenotypic activation of circulating helper memory T cells in scleroderma: Correlation with disease activity","volume":"52","author":"Fiocco","year":"1993","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02229871","article-title":"CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis","volume":"13","author":"Gorla","year":"1994","journal-title":"Clin Rheum."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2047-783X-15-1-44","article-title":"Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis","volume":"15","author":"Gambichler","year":"2010","journal-title":"Euro J Med Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12016-015-8505-8","article-title":"T and NK cell phenotypic abnormalities in systemic sclerosis: a cohort study and a comprehensive literature review","volume":"49","author":"Almeida","year":"2015","journal-title":"Clin Rev Allergy Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6808061","DOI":"10.1155\/2019\/6808061","article-title":"KIR\/HLA gene profile implication in systemic sclerosis patients from Mexico","volume":"2019","author":"Machado-Sulbaran","year":"2019","journal-title":"J Immunol Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/jcm8050625","article-title":"Cytometric characterization of main immunocompetent cells in patients with systemic sclerosis: relationship with disease activity and type of immunosuppressive treatment","volume":"8","author":"Gumkowska-Sroka","year":"2019","journal-title":"J Clin Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/eji.201948129","article-title":"Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sj\u00f6grens syndrome","volume":"50","author":"van der Kroef","year":"2020","journal-title":"Eur J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","article-title":"Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity","volume":"125","author":"Horikawa","year":"2005","journal-title":"J Invest Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3389\/fimmu.2019.02164","article-title":"Autoantibodies to killer cell immunoglobulin-like receptors in patients with systemic lupus erythematosus induce natural killer cell hyporesponsiveness","volume":"10","author":"Segerberg","year":"2019","journal-title":"Front Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/art.20216","article-title":"Association of killer cell immunoglobulin-like receptors with scleroderma","volume":"50","author":"Momot","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1399-0039.2006.762_6.x","article-title":"KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma","volume":"69","author":"Pellett","year":"2007","journal-title":"Tissue Antigens."},{"key":"B60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10067-016-3222-0","article-title":"The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erythematosus and systemic sclerosis","volume":"35","author":"Tozkir","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10067-016-3526-0","article-title":"Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis","volume":"36","author":"Mahmoudi","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S2255-5021(13)70007-5","article-title":"Characteristics of NK cell activity in patients with systemic sclerosis","volume":"53","author":"Salim","year":"2013","journal-title":"Rev Bras Reumatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/08923973.2016.1194429","article-title":"KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients","volume":"38","author":"Velarde-de la Cruz","year":"2016","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2013.00008","article-title":"Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms","volume":"4","author":"Ku\u015bnierczyk","year":"2013","journal-title":"Front Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1189\/jlb.0907609","article-title":"The inhibitory collagen receptor LAIR-1 (CD305)","volume":"83","author":"Meyaard","year":"2008","journal-title":"J Leukoc Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.retram.2020.05.003","article-title":"Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: a review","volume":"68","author":"Guo","year":"2020","journal-title":"Curr Res Transl Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/rheumatology\/keq050","article-title":"Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections","volume":"49","author":"Kimoto","year":"2010","journal-title":"Rheumatology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/rheumatology\/ket220","article-title":"Anti-NKG2A autoantibodies in a patient with systemic lupus erythematosus","volume":"52","author":"Hagberg","year":"2013","journal-title":"Rheumatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.38999","article-title":"Functional anti-CD94\/NKG2A and Anti-CD94\/NKG2C autoantibodies in patients with systemic lupus erythematosus","volume":"67","author":"Hagberg","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B71","first-page":"171","article-title":"A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus","volume":"23","author":"Yabuhara","year":"1996","journal-title":"J Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/art.24556","article-title":"Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus","volume":"60","author":"Park","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.4049\/jimmunol.1700588","article-title":"Downregulation of CD3\u03b6 in NK Cells from systemic lupus erythematosus patients confers a proinflammatory phenotype","volume":"200","author":"Su\u00e1rez-Fueyo","year":"2018","journal-title":"J Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/BOR.0000000000000195","article-title":"Update on the immunobiology of Sj\u00f6gren's syndrome","volume":"27","author":"Ambrosi","year":"2015","journal-title":"Curr Opin Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"195ra96","DOI":"10.1126\/scitranslmed.3005727","article-title":"NCR3\/NKp30 contributes to pathogenesis in primary Sjogren's syndrome","volume":"5","author":"Rusakiewicz","year":"2013","journal-title":"Sci Transl Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/sji.12622","article-title":"Patients with primary Sj\u00f6gren's syndrome have alterations in absolute quantities of specific peripheral leucocyte populations","volume":"86","author":"Davies","year":"2017","journal-title":"Scand J Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"7523914","DOI":"10.1155\/2020\/7523914","article-title":"The increased ratio of blood CD56(bright) NK to CD56(dim) NK is a distinguishing feature of primary sj\u00f6gren's syndrome","volume":"2020","author":"Ming","year":"2020","journal-title":"J Immunol Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.molimm.2017.07.007","article-title":"Effect of anti-muscarinic autoantibodies on leukocyte function in Sj\u00f6gren's syndrome","volume":"90","author":"Namkoong","year":"2017","journal-title":"Mol Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/1529-0131(200102)44:2&lt;384::AID-ANR57&gt;3.0.CO;2-Z","article-title":"Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases","volume":"44","author":"Matsui","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.humimm.2013.06.015","article-title":"Distribution of killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population","volume":"74","author":"Prakash","year":"2013","journal-title":"Hum Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"13028","DOI":"10.1073\/pnas.1000546107","article-title":"Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis","volume":"107","author":"Soderstrom","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/genes11050492","article-title":"Differentially expressed genes of natural killer cells can distinguish rheumatoid arthritis patients from healthy controls","volume":"11","author":"Elemam","year":"2020","journal-title":"Genes."},{"key":"B87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/ahg.12351","article-title":"Integrative analysis of genome-wide association study and expression quantitative trait loci datasets identified various immune cell-related pathways for rheumatoid arthritis","volume":"84","author":"Ping","year":"2020","journal-title":"Ann Hum Genet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/03009742.2019.1634755","article-title":"T cells, natural killer cells, and \u03b3\u03b4T cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy","volume":"49","author":"Schwaneck","year":"2020","journal-title":"Scand J Rheumatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1471-2474-15-256","article-title":"Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment","volume":"15","author":"Majorczyk","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B90","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1038\/s41598-020-62654-z","article-title":"Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3892\/etm.2018.6643","article-title":"Expression levels of IL-15 and IL-17 in synovial fluid of rheumatoid arthritis animal model","volume":"16","author":"Jin","year":"2018","journal-title":"Exp Ther Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/s10165-009-0160-6","article-title":"A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis","volume":"19","author":"Aramaki","year":"2009","journal-title":"Mod Rheumatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10067-014-2641-z","article-title":"Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis","volume":"33","author":"Aggarwal","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41598-018-37448-z","article-title":"High percentages and activity of synovial fluid NK cells present in patients with advanced stage active Rheumatoid Arthritis","volume":"9","author":"Yamin","year":"2019","journal-title":"Sci Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","article-title":"Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta","volume":"28","author":"Saraste","year":"2007","journal-title":"Neurol Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","article-title":"Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus","volume":"126","author":"Schepis","year":"2009","journal-title":"Immunology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12881-019-0754-6","article-title":"Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis","volume":"20","author":"Aghaei","year":"2019","journal-title":"BMC Med Genet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1155\/2012\/486320","article-title":"Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis","volume":"33","author":"Ramirez-De los Santos","year":"2012","journal-title":"Dis Markers."},{"key":"B99","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.humimm.2014.05.014","article-title":"Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population","volume":"75","author":"Prakash","year":"2014","journal-title":"Hum Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5455\/medarh.2019.73.374-377","article-title":"Expression of NK (CD16+56+) and B cells (CD19) receptor molecules as a reliable clinical response biomarkers of SLE and RA patients under the rituximab treatment","volume":"73","author":"Zecevic","year":"2019","journal-title":"Med Arch."},{"key":"B101","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5114\/ceji.2019.92777","article-title":"Natural killer cells as participants in pathogenesis of rat experimental autoimmune encephalomyelitis (EAE): lessons from research on rats with distinct age and strain","volume":"44","author":"Djureti\u0107","year":"2019","journal-title":"Cent Eur J Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/jcm9051450","article-title":"CD56bright natural killer cells: a possible biomarker of different treatments in multiple sclerosis","volume":"9","author":"Laroni","year":"2020","journal-title":"J Clin Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12974-020-01847-9","article-title":"Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis","volume":"17","author":"Gilmore","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1212\/NXI.0000000000000289","article-title":"Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis","volume":"3","author":"Gross","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B105","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhepr.2019.09.003","article-title":"KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis","volume":"1","author":"Umemura","year":"2019","journal-title":"JHEP Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/03009742.2017.1340510","article-title":"Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behcet's disease","volume":"47","author":"Mohammad-Ebrahim","year":"2018","journal-title":"Scand J Rheumatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-018-1162-7","article-title":"The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis","volume":"67","author":"Fathollahi","year":"2018","journal-title":"Inflamm Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.1038\/s41598-017-13412-1","article-title":"NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-019-1687-x","article-title":"CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells","volume":"16","author":"Yang","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B111","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/eji.200839116","article-title":"A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC","volume":"39","author":"Boles","year":"2009","journal-title":"Eur J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13223-017-0188-7","article-title":"Elevated expression of TIGIT on CD3 <sup>+<\/sup>CD4 <sup>+<\/sup> T cells correlates with disease activity in systemic lupus erythematosus","volume":"13","author":"Luo","year":"2017","journal-title":"Allergy Asthma Clin Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/imm.12715","article-title":"TIGIT signalling pathway negatively regulates CD4 < sup>+ < \/sup> T-cell responses in systemic lupus erythematosus","volume":"151","author":"Mao","year":"2017","journal-title":"Immunology."},{"key":"B114","first-page":"2408","article-title":"Decreased expression of TIGIT in NK cells correlates negatively with disease activity in systemic lupus erythematosus","volume":"11","author":"Luo","year":"2018","journal-title":"Int J Clin Exp Pathol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yexcr.2015.12.002","article-title":"TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models","volume":"340","author":"Zhao","year":"2016","journal-title":"Exp Cell Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/eji.201545480","article-title":"TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals","volume":"45","author":"Wang","year":"2015","journal-title":"Eur J Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/cei.13422","article-title":"Low-dose IL-2 induces CD56(bright) NK regulation of T cells via NKp44 and NKp46","volume":"200","author":"McQuaid","year":"2020","journal-title":"Clin Exp Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e20191421","DOI":"10.1084\/jem.2019142103192020c","article-title":"NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS","volume":"217","author":"Louis","year":"2020","journal-title":"J Exp Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/jcmm.14081","article-title":"CD83(+) CCR7(+) NK cells induced by interleukin 18 by dendritic cells promote experimental autoimmune uveitis","volume":"23","author":"Fu","year":"2019","journal-title":"J Cell Mol Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e000669","DOI":"10.1136\/rmdopen-2018-000669","article-title":"Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies","volume":"4","author":"Gladman","year":"2018","journal-title":"RMD Open."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s40265-018-0971-x","article-title":"Beyond the TNF-\u03b1 inhibitors: new and emerging targeted therapies for patients with axial spondyloarthritis and their relation to pathophysiology","volume":"78","author":"Pedersen","year":"2018","journal-title":"Drugs."},{"key":"B122","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.119.256602","article-title":"A reduction in B, T, and natural killer cells expressing CD38 by TAK-079 inhibits the induction and progression of collagen-induced arthritis in cynomolgus monkeys","volume":"370","author":"Korver","year":"2019","journal-title":"J Pharmacol Exp Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.616853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:24:47Z","timestamp":1697891087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.616853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":122,"alternative-id":["10.3389\/fimmu.2021.616853"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.616853","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"article-number":"616853"}}